Dr Reddys Laboratories Growth Metrics (2017-2025) | RDY

Growth Metrics Sep2017 Dec2017 Mar2018 Jun2018 Mar2019 Mar2020 Sep2020 Dec2020 Mar2021 Mar2022 Mar2023 Mar2024 Mar2025
Growth Ratios
Cash & Equivalents Growth (1y) -21.95%-15.63%651.85%-3.45%-64.29%21.43%102.35%
Cash & Equivalents Growth (3y) 70.44%82.97%37.38%-25.19%-4.26%
Cash & Equivalents Growth (5y) 11.29%21.58%44.82%
Enterprise Value Growth (1y) 7.60%9.00%-0.08%53.05%-10.75%0.46%28.84%-8.13%
Enterprise Value Growth (3y) 26.31%26.23%18.57%10.93%11.12%4.93%5.94%
Enterprise Value Growth (5y) 8.37%12.05%10.19%
Enterprise Value (QoQ) -3,485.62%1.97%123.86%-86.41%-25.53%3,374.39%
Property, Plant & Equipment (Net) Growth (1y) -1.07%-12.04%-11.25%12.54%4.87%-1.22%14.09%23.94%
Property, Plant & Equipment (Net) Growth (3y) 9,302.75%9,355.54%-4.23%1.55%5.24%5.73%11.78%
Property, Plant & Equipment (Net) Growth (5y) -1.87%3.37%10.51%
Property, Plant & Equipment (Net) (QoQ) -100.00%0.55%97,477,970.18%-6.30%2.25%1.30%
Revenue Growth (1y) 99.28%
Revenue (QoQ) 30.71%
Shareholder's Equity Growth (1y) 5.66%
Shareholder's Equity Growth (3y) 10,486.54%10,518.05%
Shareholder's Equity (QoQ) -100.00%1.52%95,304,337.56%3.14%2.43%
Total Debt Growth (1y) -36.47%-52.33%71.06%7.71%-75.52%112.26%138.67%
Total Debt Growth (3y) -19.69%-4.23%-23.31%-17.59%7.44%
Total Debt Growth (5y) -32.84%-14.52%17.97%